SCHEMBL195793

SCHEMBL195793

COc1ccc(C(C)=O)cc1C

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.56
KMT2A Q03164 2/20 0.56
MEN1 O00255 1/20 0.56
ALOX15 P16050 1/20 0.53
TAS1R3 Q7RTX0 5/20 0.53
TAS1R1 Q7RTX1 5/20 0.53
POLB P06746 1/20 0.52
CYP1A2 P05177 1/20 0.52
CYP3A4 P08684 1/20 0.52
CYP2C9 P11712 1/20 0.52
TSHR P16473 1/20 0.52
CYP2C19 P33261 1/20 0.52
LMNA P02545 1/20 0.52
CA12 O43570 1/20 0.50
CA1 P00915 1/20 0.50
CA2 P00918 1/20 0.50
CA4 P22748 1/20 0.50
CA6 P23280 1/20 0.50
CA7 P43166 1/20 0.50
TPMT P51580 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31003218 1.00 ALDH1A1 (0.56) ALDH1A1KMT2AMEN1ALOX15TAS1R3
SCHEMBL11577171 0.86 CYP1A2 (0.70) ALDH1A1ALOX15TAS1R3TAS1R1CYP1A2
SCHEMBL14499485 0.85 FFAR1 (0.49) ALDH1A1KMT2AMEN1ALOX15TAS1R3
SCHEMBL701782 0.84 CA12 (0.71) ALDH1A1ALOX15TAS1R3TAS1R1CYP1A2
SCHEMBL801748 0.84 LMNA (0.57) ALDH1A1KMT2AMEN1TAS1R3TAS1R1
SCHEMBL29399077 0.83 TSHR (0.73) ALDH1A1KMT2AMEN1POLBCYP1A2
SCHEMBL27753902 0.83 TSHR (0.73) ALDH1A1KMT2AMEN1POLBCYP1A2
SCHEMBL76834 0.83 TSHR (0.73) ALDH1A1KMT2AMEN1POLBCYP1A2
SCHEMBL16950467 0.83 ALOX15 (0.56) ALDH1A1ALOX15TAS1R3TAS1R1CYP1A2
SCHEMBL24890475 0.82 ALOX15 (0.51) ALDH1A1ALOX15TAS1R3TAS1R1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 179 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-107337596-B Preparation method of 4-methoxy-1, 3-phthalic acid 天津理工大学 2020-06-23 CN claimed
CN-101987825-A Method for preparing 2-amino-3-methyl-4-methoxy acetophenone SHANGPHARMA CO LTD 2011-03-23 CN claimed
US-20250346597-A1 CONDENSED HETEROCYCLIC COMPOUNDS AS INHIBITOR OF DIACYLGLYCEROL KINASES BEONE MEDICINES I GMBH (CH) 2025-11-13 US disclosed
CN-119735583-A Flavone-dihydropyrazole derivative and preparation method and application thereof 合肥工业大学 2025-04-01 CN disclosed
US-20250064823-A1 THIADIAZINE DERIVATIVES RICHTER GEDEON NYRT (HU) 2025-02-27 US disclosed
US-12194050-B2 Thiadiazine derivatives RICHTER GEDEON NYRT. (HU) 2025-01-14 US disclosed
EP-3741759-B1 IMIDAZO[1,2-A]PYRIMIDINE AND IMIDAZO[1,2-C]PYRIMIDINE COMPOUNDS AND USE THEREOF IN THE TREATMENT OF HYPERURICEMIA AND GOUT EVOPOINT BIOSCIENCES CO LTD (CN) 2023-08-23 EP disclosed
CN-116444443-A Benzoyl-quinazolinone derivative, and preparation method and application thereof 广东省中医院(广州中医药大学第二附属医院、广州中医药大学第二临床医学院、广东省中医药科学院) 2023-07-18 CN disclosed
WO-2023113510-A1 MACROCYCLIC PYRIMIDINE DERIVATIVE, METHOD FOR PREPARING SAME, AND PHARMACEUTICAL COMPOSITION FOR PREVENTION OR TREATMENT OF NEURODEGENERATIVE DISEASE CONTAINING SAME AS ACTIVE INGREDIENT 환인제약 주식회사 2023-06-22 WO disclosed
EP-3130584-B1 AROMATIC COMPOUND AND USES THEREOF SUMITOMO CHEMICAL CO (JP) 2023-04-26 EP disclosed
EP-3020715-B1 TETRAZOLINONE COMPOUND AND USE THEREOF SUMITOMO CHEMICAL CO (JP) 2021-06-16 EP disclosed
EP-0191496-A2 Triazine Derivatives, a process for preparing the derivatives, and herbicides containing the derivatives as the effective component IDEMITSU KOSAN COMPANY LIMITED (JP) 1986-08-20 EP disclosed
CN-86100884-A Process for preparing triazine derivatives and herbicides containing the derivatives as active ingredient 1986-08-13 CN disclosed
EP-0005379-B2 PHOTOSENSITIVE COMPOSITIONS CONTAINING CARBONYLIC HALIDES AS ACTIVATORS Dynachem Corporation (US) 1986-06-04 EP disclosed
US-4552830-A UNSATURATED COMPOUND, FREE RADICAL-PRODUCING PHOTOINITIATOR FLUORA COLOR FORMER, PROTON DONOR DYNACHEM CORPORATION (US) 1985-11-12 US disclosed
US-4343885-A PHOTORESISTS DYNACHEM CORPORATION (US) 1982-08-10 US disclosed
EP-0005380-B1 PHOTOTROPIC PHOTOSENSITIVE COMPOSITIONS CONTAINING A FLUORAN COLORFORMER Dynachem Corporation (US) 1982-01-06 EP disclosed
EP-0005379-B1 PHOTOSENSITIVE COMPOSITIONS CONTAINING CARBONYLIC HALIDES AS ACTIVATORS Dynachem Corporation (US) 1981-12-23 EP disclosed
EP-0005379-A2 Photosensitive compositions containing carbonylic halides as activators Dynachem Corporation (US) 1979-11-14 EP disclosed
EP-0005380-A2 Phototropic photosensitive compositions containing a fluoran colorformer Dynachem Corporation (US) 1979-11-14 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12194050-B2 Thiadiazine derivatives CHRNA5, CHRNA7, CHRNA1 ALDH1A1 390/4885KMT2A 4470/4885MEN1 2977/4885
US-20250346597-A1 CONDENSED HETEROCYCLIC COMPOUNDS AS INHIBITOR OF DIACYLGLYCEROL KINASES DGKG, DGKA, DGKK ALDH1A1 4075/4885KMT2A 2375/4885MEN1 3220/4885
US-20250064823-A1 THIADIAZINE DERIVATIVES CHRNA5, CHRNA7, CHRM5 ALDH1A1 432/4885KMT2A 4482/4885MEN1 3134/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.